Serum glucagon, bile acids, and FGF-19: metabolic behavior patterns after Roux-en-Y gastric bypass and vertical sleeve gastrectomy

Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly afte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yang, Cui (VerfasserIn) , Brecht, Julia (VerfasserIn) , Weiß, Christel (VerfasserIn) , Reißfelder, Christoph (VerfasserIn) , Otto, Mirko (VerfasserIn) , Buchwald, Jane N. (VerfasserIn) , Vassilev, Georgi (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 2021
In: Obesity surgery
Year: 2021, Jahrgang: 31, Heft: 11, Pages: 4939-4946
ISSN:1708-0428
DOI:10.1007/s11695-021-05677-3
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11695-021-05677-3
Volltext
Verfasserangaben:Cui Yang, Julia Brecht, Christel Weiß, Christoph Reissfelder, Mirko Otto, Jane N. Buchwald, Georgi Vassilev
Beschreibung
Zusammenfassung:Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly after Roux-en-Y gastric bypass (RYGB) vs vertical sleeve gastrectomy (VSG).
Beschreibung:Published online: 30 August 2021
Gesehen am 02.06.2023
Beschreibung:Online Resource
ISSN:1708-0428
DOI:10.1007/s11695-021-05677-3